Skip to main content

Animations

MJFF Publications

251 - 260 of 8404 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.97228.3
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Pointing in the right direction: Greater motor improvements with directional versus circular subthalamic nucleus deep brain stimulation for Parkinson's disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241301071
    Citation Count: 1
  • Summary Details
    OPEN
    Title: NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis
    Journal Name: Journal of Cachexia, Sarcopenia and Muscle
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jcsm.13672
    Citation Count: 1
  • Summary Details
    OPEN
    Title: RNApysoforms: fast rendering interactive visualization of RNA isoform structure and expression in Python
    Journal Name: Bioinformatics Advances
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioadv/vbaf057
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Tagless LysoIP for immunoaffinity enrichment of native lysosomes from clinical samples
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci183592
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Developing Allosteric Chaperones for GBA1-Associated Disorders—An Integrated Computational and Experimental Approach
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms26010009
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Non-motor asymmetry and dopamine degeneration in Parkinson’s disease
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcaf002
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.27158
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14448
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: α‐Synuclein Gene Hypomethylation in LRRK2 Parkinson's Disease Patients
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30094
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.